Site Management Organization Market – Distribution by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phases (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035
The site management organization market is expected to reach USD 8.5 million by 2021 anticipated to grow at a CAGR of 10% during the forecast period 2021-2035
Clinical trials constitute a pivotal element in drug development, crucial for evaluating a candidate's safety and efficacy. Statistics suggest that about 40% of the investment in drug development, amounting to roughly USD 78 billion annually, is directed towards these trials. However, conducting these trials poses several challenges, spanning scientific and operational complexities, difficulties in recruitment and retention, concerns regarding data management, and stricter regulatory requirements. The involvement of various stakeholders in this multifaceted process often results in delays, with over 80% of trials being postponed by one to six months, and only 10% completing on schedule. Consequently, the pharmaceutical industry continuously seeks ways to improve the clinical trial process and its management. Among several strategies, outsourcing trial operations to specialized service providers, such as site management organizations (SMOs), has emerged as a viable option. Involving these providers offers numerous advantages, enabling sponsors to adhere to research timelines. SMOs can expedite patient recruitment, shorten study durations, and oversee the entire trial process and administrative tasks for their clients. Moreover, pharmaceutical innovators, contract research organizations (CROs), and even developers of medical devices can utilize SMOs' therapeutic and operational expertise, global site networks, and established processes to conduct clinical research and manage sites efficiently in terms of both time and cost. Presently, approximately 250 companies claim to actively provide SMO services to drug and medical device developers worldwide. Recent developments in the site management market focus on consolidating capabilities, expanding service portfolios, and collaborating to broaden geographical coverage. These trends arise from sponsor companies' preference for comprehensive service providers and the increasing recognition of outsourcing as a beneficial model for clinical trial management and research site administration. With the growing complexity and registration of more clinical trials, the demand for SMOs is expected to experience steady market growth in the forecast period.
Report Coverage
Clinical trials constitute a pivotal element in drug development, crucial for evaluating a candidate's safety and efficacy. Statistics suggest that about 40% of the investment in drug development, amounting to roughly USD 78 billion annually, is directed towards these trials. However, conducting these trials poses several challenges, spanning scientific and operational complexities, difficulties in recruitment and retention, concerns regarding data management, and stricter regulatory requirements. The involvement of various stakeholders in this multifaceted process often results in delays, with over 80% of trials being postponed by one to six months, and only 10% completing on schedule. Consequently, the pharmaceutical industry continuously seeks ways to improve the clinical trial process and its management. Among several strategies, outsourcing trial operations to specialized service providers, such as site management organizations (SMOs), has emerged as a viable option. Involving these providers offers numerous advantages, enabling sponsors to adhere to research timelines. SMOs can expedite patient recruitment, shorten study durations, and oversee the entire trial process and administrative tasks for their clients. Moreover, pharmaceutical innovators, contract research organizations (CROs), and even developers of medical devices can utilize SMOs' therapeutic and operational expertise, global site networks, and established processes to conduct clinical research and manage sites efficiently in terms of both time and cost. Presently, approximately 250 companies claim to actively provide SMO services to drug and medical device developers worldwide. Recent developments in the site management market focus on consolidating capabilities, expanding service portfolios, and collaborating to broaden geographical coverage. These trends arise from sponsor companies' preference for comprehensive service providers and the increasing recognition of outsourcing as a beneficial model for clinical trial management and research site administration. With the growing complexity and registration of more clinical trials, the demand for SMOs is expected to experience steady market growth in the forecast period.
Report Coverage
- The report examines the site management organization market, focusing on therapeutic areas, trial phases, clinical trial components, types of interventions, and key geographical regions.
- It analyzes various factors impacting market growth, including drivers, restraints, opportunities, and challenges.
- Assessing both potential advantages and obstacles within the market, the report provides insights for stakeholders and details the competitive landscape among top market players.
- Revenue forecasts are provided for market segments across six major regions.
- It offers an overview of companies offering services to Contract Research Organizations (CROs), pharmaceutical, biotech, and medical device firms. Information includes establishment year, employee count, headquarters location, offered services (e.g., site selection, patient recruitment), therapeutic expertise, and global reach.
- The evaluation of service providers considers headquarters location (North America, Europe, Asia-Pacific & RoW) and employee count (small, mid-sized, large). It highlights key players in site management based on their capabilities.
- Examining partnerships in the site management market (e.g., acquisitions, joint ventures) involves analyzing types, years, focus areas, and active participants. Insights on regional distribution of collaborations are provided.
- A detailed breakdown of investments received by site management organizations includes year-wise data, funding types, investor types, active players, and investor distribution by geography.
- Insights on completed, ongoing, and planned clinical studies encompass trial registration year, patient enrollment, status, phase, sponsor type, and geographical distribution.
- Estimations of the yearly demand for clinical trial participants are based on ongoing and planned trials sponsored by both industry and non-industry entities.
- Detailed profiles of selected top players offering Site Management Organization (SMO) services in North America, Europe, and Asia-Pacific. Information includes establishment year, employee count, headquarters location, service portfolio, recent developments, and future outlook.
- FOMAT Medical Research
- Parexel
- Pharm-Olam
- Veristat
- WCCT Global
- Worldwide Clinical Trials
- CROMSOURCE
- Fidelis Research
- Scandinavian CRO
- Trialbee
- CMIC Group
- George Clinical
- Tigermed
- Veeda Clinical Research
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Site Management Organizations
3.3. Role of Site Management Organizations in Clinical Trials
3.4. Services Offered by Site Management Organizations
3.5. Advantages of One-Stop-Shops
3.6. Concluding Remarks
4. COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Site Management Organizations: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Service(s) Offered
4.2.5. Analysis by Therapeutic Expertise
4.2.6. Analysis by Geographical Reach
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Site Management Organizations: Company Competitiveness Analysis
5.4.1. Competitiveness Analysis: Site Management Organizations in North America
5.4.1.1. Competitiveness Analysis: Small Companies in North America
5.4.1.2. Competitiveness Analysis: Mid-sized Companies in North America
5.4.1.3. Competitiveness Analysis: Large Companies in North America
5.4.2. Competitiveness Analysis: Site Management Organizations in Europe
5.4.2.1. Competitiveness Analysis: Small Companies in Europe
5.4.2.2. Competitiveness Analysis: Mid-sized Companies in Europe
5.4.2.3. Competitiveness Analysis: Large Companies in Europe
5.4.3. Competitiveness Analysis: Site Management Organizations in Asia-Pacific and Rest of the World
5.4.3.1. Competitiveness Analysis: Small Companies in Asia-Pacific and Rest of the World
5.4.3.2. Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
5.4.3.3. Competitiveness Analysis: Large Companies in Asia-Pacific and Rest of the World
6. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN NORTH AMERICA
6.1. Chapter Overview
6.2. FOMAT Medical Research
6.2.1. Company Overview
6.2.2. Clinical Trial Site Management Services
6.2.3. Recent Developments and Future Outlook
6.3. Parexel
6.3.1. Company Overview
6.3.2. Clinical Trial Site Management Services
6.3.3. Recent Developments and Future Outlook
6.4. Pharm-Olam
6.4.1. Company Overview
6.4.2. Clinical Trial Site Management Services
6.4.3. Recent Developments and Future Outlook
6.5. Veristat
6.5.1. Company Overview
6.5.2. Clinical Trial Site Management Services
6.5.3. Recent Developments and Future Outlook
6.6. WCCT Global
6.6.1. Company Overview
6.6.2. Clinical Trial Site Management Services
6.6.3. Recent Developments and Future Outlook
6.7. Worldwide Clinical Trials
6.7.1. Company Overview
6.7.2. Clinical Trial Site Management Services
6.7.3. Recent Developments and Future Outlook
7. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN EUROPE
7.1. Chapter Overview
7.2. CROMSOURCE
7.2.1. Company Overview
7.2.2. Clinical Trial Site Management Services
7.2.3. Recent Developments and Future Outlook
7.3. Fidelis Research
7.3.1. Company Overview
7.3.2. Clinical Trial Site Management Services
7.3.3. Recent Developments and Future Outlook
7.4. Scandinavian CRO
7.4.1. Company Overview
7.4.2. Clinical Trial Site Management Services
7.4.3. Recent Developments and Future Outlook
7.5. TFS HealthScience
7.5.1. Company Overview
7.5.2. Clinical Trial Site Management Services
7.5.3. Recent Developments and Future Outlook
7.6. Trialbee
7.6.1. Company Overview
7.6.2. Clinical Trial Site Management Services
7.6.3. Recent Developments and Future Outlook
8. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN ASIA-PACIFIC
8.1. Chapter Overview
8.2. CMIC Group
8.2.1. Company Overview
8.2.2. Clinical Trial Site Management Services
8.2.3. Recent Developments and Future Outlook
8.3. George Clinical
8.3.1. Company Overview
8.3.2. Clinical Trial Site Management Service
8.3.3. Recent Developments and Future Outlook
8.4. Tigermed
8.4.1. Company Overview
8.4.2. Clinical Trial Site Management Services
8.4.3. Recent Developments and Future Outlook
8.5. Veeda Clinical Research
8.5.1. Company Overview
8.5.2. Clinical Trial Site Management Services
8.5.3. Recent Developments and Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Site Management Organizations: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.3.6. Geographical Analysis
9.3.6.1. Region-wise Distribution
9.3.6.2. Country-wise Distribution
10. FUNDING AND INVESTMENT ANALYSIS
10.1. Chapter Overview
10.2. Types of Funding
10.3. Site Management Organizations: Funding and Investment Analysis
10.3.1. Analysis by Year of Investment
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Year-wise Analysis by Type of Funding and Amount Invested
10.3.5. Most Active Players: Analysis by Number of Funding Instances
10.3.6. Most Active Investors: Analysis by Number of Funding Instances
10.3.7. Analysis by Type of Investor
10.3.8. Analysis by Geography
11. KEY INSIGHTS FROM CLINICAL TRIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Site Management Organizations: Clinical Trial Key Insights
11.3.1. Analysis by Trial Registration Year
11.3.2. Analysis by Trial Registration Year and Enrolled Patient Population
11.3.3. Analysis by Trial Status
11.3.4. Analysis by Trial Registration Year and Trial Status
11.3.5. Analysis by Trial Phase
11.3.6. Analysis by Trial Phase and Enrolled Patient Population
11.3.7. Analysis by Trial Registration Year and Trial Phase (in term of Number of Clinical Trials)
11.3.8. Analysis by Trial Registration Year and Trial Phase (in terms of Number of Enrolled Patient Population)
11.3.9. Analysis by Type of Sponsor / Collaborator
11.3.10. Geographical Analysis by Number of Clinical Trials
11.3.11. Geographical Analysis by Enrolled Patient Population
12. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
12.1. Chapter Overview
12.2. Methodology and Key Assumptions
12.3. Global Demand for Clinical Trial Participants: Analysis by Enrolled Patient Population
12.3.1. Analysis of Demand by Trial Phase
12.3.2. Analysis of Demand by Therapeutic Area
12.3.3. Geographical Demand by Enrolled Patient Population
13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Global Site Management Organizations Market, 2021-2035
13.4. Site Management Organizations Market, 2021 and 2035: Distribution by Therapeutic Area
13.5. Site Management Organizations Market, 2021-2035: Distribution by Trial Phase
13.6. Site Management Organizations Market, 2021-2035: Distribution by Clinical Trial Components
13.7. Site Management Organizations Market, 2021-2035: Distribution by Type of Intervention
13.8. Site Management Organizations Market, 2021 and 2035: Distribution by Region
13.8.1. Site Management Organizations Market, 2021 and 2035: Distribution by Country
13.8.2. Site Management Organizations Market in North America, 2021-2035
13.8.2.1. Site Management Organizations Market in the US, 2021-2035
13.8.2.2. Site Management Organizations Market in Canada, 2021-2035
13.8.2.3. Site Management Organizations Market in Rest of North America, 2021-2035
13.8.3. Site Management Organizations Market in Europe, 2021-2035
13.8.3.1. Site Management Organizations Market in the UK, 2021-2035
13.8.3.2. Site Management Organizations Market in France, 2021-2035
13.8.3.3. Site Management Organizations Market in Germany, 2021-2035
13.8.3.4. Site Management Organizations Market in Spain, 2021-2035
13.8.3.5. Site Management Organizations Market in Italy, 2021-2035
13.8.3.6. Site Management Organizations Market in Rest of Europe, 2021-2035
13.8.4. Site Management Organizations Market in Asia-Pacific, 2021-2035
13.8.4.1. Site Management Organizations Market in China, 2021-2035
13.8.4.2. Site Management Organizations Market in Korea, 2021-2035
13.8.4.3. Site Management Organizations Market in India, 2021-2035
13.8.4.4. Site Management Organizations Market in Australia, 2021-2035
13.8.4.5. Site Management Organizations Market in Japan, 2021-2035
13.8.4.6. Site Management Organizations Market in Israel, 2021-2035
13.8.4.7. Site Management Organizations Market in Rest of Asia-Pacific, 2021-2035
13.8.5. Site Management Organizations Market in Latin America, 2021-2035
13.8.6. Site Management Organizations Market in MENA, 2021-2035
13.8.7. Site Management Organizations Market in Rest of the World, 2021-2035
14. CONCLUDING REMARKS
15. EXECUTIVE INSIGHTS
15.1. Chapter Overview
15.2. GDD Experts
15.2.1. Company Snapshot
15.2.2. Interview Transcript: Vinod Gyanchandani, Country Head-Clinical Operations
15.3. SMO – Dra. Marisa Vico
15.3.1. Company Snapshot
15.3.2. Interview Transcript: Marisa Vico, Medical Director and Operations Manager
15.4. Syncretic Clinical Research Services
15.4.1. Company Snapshot
15.4.2. Interview Transcript: Eugene Winifred, Project Manager
16. APPENDIX 1: TABULATED DATA
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Site Management Organizations
3.3. Role of Site Management Organizations in Clinical Trials
3.4. Services Offered by Site Management Organizations
3.5. Advantages of One-Stop-Shops
3.6. Concluding Remarks
4. COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Site Management Organizations: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Service(s) Offered
4.2.5. Analysis by Therapeutic Expertise
4.2.6. Analysis by Geographical Reach
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Site Management Organizations: Company Competitiveness Analysis
5.4.1. Competitiveness Analysis: Site Management Organizations in North America
5.4.1.1. Competitiveness Analysis: Small Companies in North America
5.4.1.2. Competitiveness Analysis: Mid-sized Companies in North America
5.4.1.3. Competitiveness Analysis: Large Companies in North America
5.4.2. Competitiveness Analysis: Site Management Organizations in Europe
5.4.2.1. Competitiveness Analysis: Small Companies in Europe
5.4.2.2. Competitiveness Analysis: Mid-sized Companies in Europe
5.4.2.3. Competitiveness Analysis: Large Companies in Europe
5.4.3. Competitiveness Analysis: Site Management Organizations in Asia-Pacific and Rest of the World
5.4.3.1. Competitiveness Analysis: Small Companies in Asia-Pacific and Rest of the World
5.4.3.2. Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
5.4.3.3. Competitiveness Analysis: Large Companies in Asia-Pacific and Rest of the World
6. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN NORTH AMERICA
6.1. Chapter Overview
6.2. FOMAT Medical Research
6.2.1. Company Overview
6.2.2. Clinical Trial Site Management Services
6.2.3. Recent Developments and Future Outlook
6.3. Parexel
6.3.1. Company Overview
6.3.2. Clinical Trial Site Management Services
6.3.3. Recent Developments and Future Outlook
6.4. Pharm-Olam
6.4.1. Company Overview
6.4.2. Clinical Trial Site Management Services
6.4.3. Recent Developments and Future Outlook
6.5. Veristat
6.5.1. Company Overview
6.5.2. Clinical Trial Site Management Services
6.5.3. Recent Developments and Future Outlook
6.6. WCCT Global
6.6.1. Company Overview
6.6.2. Clinical Trial Site Management Services
6.6.3. Recent Developments and Future Outlook
6.7. Worldwide Clinical Trials
6.7.1. Company Overview
6.7.2. Clinical Trial Site Management Services
6.7.3. Recent Developments and Future Outlook
7. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN EUROPE
7.1. Chapter Overview
7.2. CROMSOURCE
7.2.1. Company Overview
7.2.2. Clinical Trial Site Management Services
7.2.3. Recent Developments and Future Outlook
7.3. Fidelis Research
7.3.1. Company Overview
7.3.2. Clinical Trial Site Management Services
7.3.3. Recent Developments and Future Outlook
7.4. Scandinavian CRO
7.4.1. Company Overview
7.4.2. Clinical Trial Site Management Services
7.4.3. Recent Developments and Future Outlook
7.5. TFS HealthScience
7.5.1. Company Overview
7.5.2. Clinical Trial Site Management Services
7.5.3. Recent Developments and Future Outlook
7.6. Trialbee
7.6.1. Company Overview
7.6.2. Clinical Trial Site Management Services
7.6.3. Recent Developments and Future Outlook
8. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN ASIA-PACIFIC
8.1. Chapter Overview
8.2. CMIC Group
8.2.1. Company Overview
8.2.2. Clinical Trial Site Management Services
8.2.3. Recent Developments and Future Outlook
8.3. George Clinical
8.3.1. Company Overview
8.3.2. Clinical Trial Site Management Service
8.3.3. Recent Developments and Future Outlook
8.4. Tigermed
8.4.1. Company Overview
8.4.2. Clinical Trial Site Management Services
8.4.3. Recent Developments and Future Outlook
8.5. Veeda Clinical Research
8.5.1. Company Overview
8.5.2. Clinical Trial Site Management Services
8.5.3. Recent Developments and Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Site Management Organizations: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.3.6. Geographical Analysis
9.3.6.1. Region-wise Distribution
9.3.6.2. Country-wise Distribution
10. FUNDING AND INVESTMENT ANALYSIS
10.1. Chapter Overview
10.2. Types of Funding
10.3. Site Management Organizations: Funding and Investment Analysis
10.3.1. Analysis by Year of Investment
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Year-wise Analysis by Type of Funding and Amount Invested
10.3.5. Most Active Players: Analysis by Number of Funding Instances
10.3.6. Most Active Investors: Analysis by Number of Funding Instances
10.3.7. Analysis by Type of Investor
10.3.8. Analysis by Geography
11. KEY INSIGHTS FROM CLINICAL TRIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Site Management Organizations: Clinical Trial Key Insights
11.3.1. Analysis by Trial Registration Year
11.3.2. Analysis by Trial Registration Year and Enrolled Patient Population
11.3.3. Analysis by Trial Status
11.3.4. Analysis by Trial Registration Year and Trial Status
11.3.5. Analysis by Trial Phase
11.3.6. Analysis by Trial Phase and Enrolled Patient Population
11.3.7. Analysis by Trial Registration Year and Trial Phase (in term of Number of Clinical Trials)
11.3.8. Analysis by Trial Registration Year and Trial Phase (in terms of Number of Enrolled Patient Population)
11.3.9. Analysis by Type of Sponsor / Collaborator
11.3.10. Geographical Analysis by Number of Clinical Trials
11.3.11. Geographical Analysis by Enrolled Patient Population
12. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
12.1. Chapter Overview
12.2. Methodology and Key Assumptions
12.3. Global Demand for Clinical Trial Participants: Analysis by Enrolled Patient Population
12.3.1. Analysis of Demand by Trial Phase
12.3.2. Analysis of Demand by Therapeutic Area
12.3.3. Geographical Demand by Enrolled Patient Population
13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Global Site Management Organizations Market, 2021-2035
13.4. Site Management Organizations Market, 2021 and 2035: Distribution by Therapeutic Area
13.5. Site Management Organizations Market, 2021-2035: Distribution by Trial Phase
13.6. Site Management Organizations Market, 2021-2035: Distribution by Clinical Trial Components
13.7. Site Management Organizations Market, 2021-2035: Distribution by Type of Intervention
13.8. Site Management Organizations Market, 2021 and 2035: Distribution by Region
13.8.1. Site Management Organizations Market, 2021 and 2035: Distribution by Country
13.8.2. Site Management Organizations Market in North America, 2021-2035
13.8.2.1. Site Management Organizations Market in the US, 2021-2035
13.8.2.2. Site Management Organizations Market in Canada, 2021-2035
13.8.2.3. Site Management Organizations Market in Rest of North America, 2021-2035
13.8.3. Site Management Organizations Market in Europe, 2021-2035
13.8.3.1. Site Management Organizations Market in the UK, 2021-2035
13.8.3.2. Site Management Organizations Market in France, 2021-2035
13.8.3.3. Site Management Organizations Market in Germany, 2021-2035
13.8.3.4. Site Management Organizations Market in Spain, 2021-2035
13.8.3.5. Site Management Organizations Market in Italy, 2021-2035
13.8.3.6. Site Management Organizations Market in Rest of Europe, 2021-2035
13.8.4. Site Management Organizations Market in Asia-Pacific, 2021-2035
13.8.4.1. Site Management Organizations Market in China, 2021-2035
13.8.4.2. Site Management Organizations Market in Korea, 2021-2035
13.8.4.3. Site Management Organizations Market in India, 2021-2035
13.8.4.4. Site Management Organizations Market in Australia, 2021-2035
13.8.4.5. Site Management Organizations Market in Japan, 2021-2035
13.8.4.6. Site Management Organizations Market in Israel, 2021-2035
13.8.4.7. Site Management Organizations Market in Rest of Asia-Pacific, 2021-2035
13.8.5. Site Management Organizations Market in Latin America, 2021-2035
13.8.6. Site Management Organizations Market in MENA, 2021-2035
13.8.7. Site Management Organizations Market in Rest of the World, 2021-2035
14. CONCLUDING REMARKS
15. EXECUTIVE INSIGHTS
15.1. Chapter Overview
15.2. GDD Experts
15.2.1. Company Snapshot
15.2.2. Interview Transcript: Vinod Gyanchandani, Country Head-Clinical Operations
15.3. SMO – Dra. Marisa Vico
15.3.1. Company Snapshot
15.3.2. Interview Transcript: Marisa Vico, Medical Director and Operations Manager
15.4. Syncretic Clinical Research Services
15.4.1. Company Snapshot
15.4.2. Interview Transcript: Eugene Winifred, Project Manager
16. APPENDIX 1: TABULATED DATA
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
